Muscle satellite cells are largely responsible for skeletal muscle regeneration following injury. Side population (SP) cells, which are thought to be muscle stem cells, also contribute to muscle regeneration. SP cells exhibit high mesenchymal potential, and are a possible cell source for therapy of muscular dystrophy. However, the mechanism by which muscle SP cells are committed to differentiation is poorly understood. microRNAs (miRNAs) play key roles in modulating a variety of cellular processes through repression of their mRNA targets. In skeletal muscle, miRNAs are known to be involved in myoblast proliferation and differentiation. To investigate mechanisms of SP cell regulation, we profiled miRNA expression in SP cells and main population (MP) cells in muscles using quantitative real-time polymerase chain reaction-based expression assays. We identified a set of miRNAs that was highly expressed in SP cells as compared with MP cells. One miRNA, miR-128a, was elevated in expression in SP cells, but decreased in expression during continued culture in vitro. Overexpression of miR-128a in SP cells resulted in inhibited cell proliferation. The differentiation potential of SP cells was also decreased when miR-128a was overexpressed. MiR-128a was found to regulate the target genes involved in the regulation of adipogenic-, osteogenic- and myogenic genes that include: PPARγ, Runx1, and Pax3. Overexpression of miR-128a suppressed the activity of a luciferase reporter fused to the 3′-untranslated region of each gene. These results demonstrate that miR-128a contributes to the maintenance of the quiescent state, and it regulates cellular differentiation by repressing individual genes in SP cells.
CollinsCA, OlsenI, ZammitPS, HeslopL, PetrieA, PartridgeTA, MorganJE. 2005. Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell, 122:289–301.
3.
KuangS, KurodaK, Le GrandF, RudnickiMA. 2007. Asymmetric self-renewal and commitment of satellite stem cells in muscle. Cell, 129:999–1010.
4.
Qu-PetersenZ, DeasyB, JankowskiR, IkezawaM, CumminsJ, PruchnicR, MytingerJ, CaoB, GatesC, WernigA, HuardJ. 2002. Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J Cell Biol, 157:851–864.
5.
JiangY, VaessenB, LenvikT, BlackstadM, ReyesM, VerfaillieCM. 2002. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol, 30:896–904.
6.
TamakiT, AkatsukaA, AndoK, NakamuraY, MatsuzawaH, HottaT, RoyRR, EdgertonVR. 2002. Identification of myogenic-endothelial progenitor cells in the interstitial spaces of skeletal muscle. J Cell Biol, 157:571–577.
7.
SampaolesiM, BlotS, D'AntonaG, GrangerN, TonlorenziR, InnocenziA, MognolP, ThibaudJL, GalvezBG. et al. 2006. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature, 444:574–579.
8.
DellavalleA, SampaolesiM, TonlorenziR, TagliaficoE, SacchettiB, PeraniL, InnocenziA, GalvezBG, MessinaG. et al. 2007. Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol, 9:255–267.
9.
GoodellMA, BroseK, ParadisG, ConnerAS, MulliganRC. 1996. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med, 183:1797–1806.
10.
PeaultB, RudnickiM, TorrenteY, CossuG, TremblayJP, PartridgeT, GussoniE, KunkelLM, HuardJ. 2007. Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol Ther, 15:867–877.
11.
AsakuraA, SealeP, Girgis-GabardoA, RudnickiMA. 2002. Myogenic specification of side population cells in skeletal muscle. J Cell Biol, 159:123–134.
12.
GussoniE, SoneokaY, StricklandCD, BuzneyEA, KhanMK, FlintAF, KunkelLM, MulliganRC. 1999. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature, 401:390–394.
13.
BachrachE, PerezAL, ChoiYH, IlligensBM, JunSJ, del NidoP, McGowanFX, LiS, FlintA, ChamberlainJ, KunkelLM. 2006. Muscle engraftment of myogenic progenitor cells following intraarterial transplantation. Muscle Nerve, 34:44–52.
14.
FrankNY, KhoAT, SchattonT, MurphyGF, MolloyMJ, ZhanQ, RamoniMF, FrankMH, KohaneIS, GussoniE. 2006. Regulation of myogenic progenitor proliferation in human fetal skeletal muscle by BMP4 and its antagonist Gremlin. J Cell Biol, 175:99–110.
15.
MotohashiN, UezumiA, YadaE, FukadaS, FukushimaK, ImaizumiK, Miyagoe-SuzukiY, TakedaS. 2008. Muscle CD31(-) CD45(-) side population cells promote muscle regeneration by stimulating proliferation and migration of myoblasts. Am J Pathol, 173:781–791.
16.
LiadakiK, KhoAT, SanoudouD, SchiendaJ, FlintA, BeggsAH, KohaneIS, KunkelLM. 2005. Side population cells isolated from different tissues share transcriptome signatures and express tissue-specific markers. Exp Cell Res, 303:360–374.
17.
RanaTM. 2007. Illuminating the silence: understanding the structure and function of small RNAs. Nat Rev Mol Cell Biol, 8:23–36.
18.
StefaniG, SlackFJ. 2008. Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol, 9:219–230.
19.
EisenbergI, EranA, NishinoI, MoggioM, LampertiC, AmatoAA, LidovHG, KangPB, NorthKN. et al. 2007. Distinctive patterns of microRNA expression in primary muscular disorders. Proc Natl Acad Sci U S A, 104:17016–17021.
20.
IveyKN, SrivastavaD. 2010. MicroRNAs as regulators of differentiation and cell fate decisions. Cell Stem Cell, 7:36–41.
21.
UezumiA, FukadaS, YamamotoN, TakedaS, TsuchidaK. 2010. Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle. Nat Cell Biol, 12:143–152.
SchmittgenTD, LivakKJ. 2008. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc, 3:1101–1108.
24.
AlexanderMS, CasarJC, MotohashiN, MyersJA, EisenbergI, GonzalezRT, EstrellaEA, KangPB, KawaharaG, KunkelLM. 2011. Regulation of DMD pathology by an ankyrin-encoded miRNA. Skelet Muscle, 1:27.
25.
UezumiA, OjimaK, FukadaS, IkemotoM, MasudaS, Miyagoe-SuzukiY, TakedaS. 2006. Functional heterogeneity of side population cells in skeletal muscle. Biochem Biophys Res Commun, 341:864–873.
26.
FingarDC, BlenisJ. 2004. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene, 23:3151–3171.
27.
LamouilleS, DerynckR. 2007. Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J Cell Biol, 178:437–451.
28.
TamakiT, AkatsukaA, OkadaY, MatsuzakiY, OkanoH, KimuraM. 2003. Growth and differentiation potential of main- and side-population cells derived from murine skeletal muscle. Exp Cell Res, 291:83–90.
29.
GeorgantasRW3rd, HildrethR, MorisotS, AlderJ, LiuCG, HeimfeldS, CalinGA, CroceCM, CivinCI. 2007. CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci U S A, 104:2750–2755.
30.
SmirnovaL, GrafeA, SeilerA, SchumacherS, NitschR, WulczynFG. 2005. Regulation of miRNA expression during neural cell specification. Eur J Neurosci, 21:1469–1477.
31.
VenkataramanS, AlimovaI, FanR, HarrisP, ForemanN, VibhakarR. 2010. MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence. PLoS One, 5:e10748.
32.
GodlewskiJ, NowickiMO, BroniszA, WilliamsS, OtsukiA, NuovoG, RaychaudhuryA, NewtonHB, ChioccaEA, LawlerS. 2008. Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res, 68:9125–9130.
33.
LeeEJ, BaekM, GusevY, BrackettDJ, NuovoGJ, SchmittgenTD. 2008. Systematic evaluation of microRNA processing patterns in tissues, cell lines, and tumors. RNA, 14:35–42.
34.
LessardJ, SauvageauG. 2003. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature, 423:255–260.
35.
ParkIK, QianD, KielM, BeckerMW, PihaljaM, WeissmanIL, MorrisonSJ, ClarkeMF. 2003. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature, 423:302–305.
36.
MolofskyAV, HeS, BydonM, MorrisonSJ, PardalR. 2005. Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev, 19:1432–1437.
WuZ, RosenED, BrunR, HauserS, AdelmantG, TroyAE, McKeonC, DarlingtonGJ, SpiegelmanBM. 1999. Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell, 3:151–158.
39.
TontonozP, HuE, SpiegelmanBM. 1994. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell, 79:1147–1156.
40.
BrunRP, TontonozP, FormanBM, EllisR, ChenJ, EvansRM, SpiegelmanBM. 1996. Differential activation of adipogenesis by multiple PPAR isoforms. Genes Dev, 10:974–984.
41.
LevanonD, BettounD, Harris-CerrutiC, WoolfE, NegreanuV, EilamR, BernsteinY, GoldenbergD, XiaoC. et al. 2002. The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons. EMBO J, 21:3454–3463.
42.
LianJB, BalintE, JavedA, DrissiH, VittiR, QuinlanEJ, ZhangL, Van WijnenAJ, SteinJL, SpeckN, SteinGS. 2003. Runx1/AML1 hematopoietic transcription factor contributes to skeletal development in vivo. J Cell Physiol, 196:301–311.
43.
SteinGS, LianJB, van WijnenAJ, SteinJL, MontecinoM, JavedA, ZaidiSK, YoungDW, ChoiJY, PockwinseSM. 2004. Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression. Oncogene, 23:4315–4329.
44.
DucyP, ZhangR, GeoffroyV, RidallAL, KarsentyG. 1997. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell, 89:747–754.
45.
OkudaT, van DeursenJ, HiebertSW, GrosveldG, DowningJR. 1996. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell, 84:321–330.
46.
WangQ, StacyT, BinderM, Marin-PadillaM, SharpeAH, SpeckNA. 1996. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc Natl Acad Sci U S A, 93:3444–3449.
47.
LevanonD, BrennerO, NegreanuV, BettounD, WoolfE, EilamR, LotemJ, GatU, OttoF, SpeckN, GronerY. 2001. Spatial and temporal expression pattern of Runx3 (Aml2) and Runx1 (Aml1) indicates non-redundant functions during mouse embryogenesis. Mech Dev, 109:413–417.
48.
BuckinghamM, RelaixF. 2007. The role of Pax genes in the development of tissues and organs: Pax3 and Pax7 regulate muscle progenitor cell functions. Annu Rev Cell Dev Biol, 23:645–673.
49.
MontanaroF, LiadakiK, SchiendaJ, FlintA, GussoniE, KunkelLM. 2004. Demystifying SP cell purification: viability, yield, and phenotype are defined by isolation parameters. Exp Cell Res, 298:144–154.
50.
KarbienerM, FischerC, NowitschS, OpriessnigP, PapakC, AilhaudG, DaniC, AmriEZ, ScheidelerM. 2009. microRNA miR-27b impairs human adipocyte differentiation and targets PPARgamma. Biochem Biophys Res Commun, 390:247–251.
51.
KimSY, KimAY, LeeHW, SonYH, LeeGY, LeeJW, LeeYS, KimJB. 2010. miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARgamma expression. Biochem Biophys Res Commun, 392:323–328.
WangQ, LiYC, WangJ, KongJ, QiY, QuiggRJ, LiX. 2008. miR-17–92 cluster accelerates adipocyte differentiation by negatively regulating tumor-suppressor Rb2/p130. Proc Natl Acad Sci U S A, 105:2889–2894.
55.
XieH, LimB, LodishHF. 2009. MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes, 58:1050–1057.
56.
LiZ, HassanMQ, VoliniaS, van WijnenAJ, SteinJL, CroceCM, LianJB, SteinGS. 2008. A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc Natl Acad Sci U S A, 105:13906–13911.
57.
ItohT, NozawaY, AkaoY. 2009. MicroRNA-141 and −200a are involved in bone morphogenetic protein-2-induced mouse pre-osteoblast differentiation by targeting distal-less homeobox 5. J Biol Chem, 284:19272–19279.
58.
LiZ, HassanMQ, JafferjiM, AqeilanRI, GarzonR, CroceCM, van WijnenAJ, SteinJL, SteinGS, LianJB. 2009. Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. J Biol Chem, 284:15676–15684.
59.
CristCG, MontarrasD, PallafacchinaG, RocancourtD, CumanoA, ConwaySJ, BuckinghamM. 2009. Muscle stem cell behavior is modified by microRNA-27 regulation of Pax3 expression. Proc Natl Acad Sci U S A, 106:13383–13387.
60.
RaoPK, KumarRM, FarkhondehM, BaskervilleS, LodishHF. 2006. Myogenic factors that regulate expression of muscle-specific microRNAs. Proc Natl Acad Sci U S A, 103:8721–8726.
ChenJF, MandelEM, ThomsonJM, WuQ, CallisTE, HammondSM, ConlonFL, WangDZ. 2006. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet, 38:228–233.
63.
HuangJ, ZhaoL, XingL, ChenD. 2010. MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells, 28:357–364.
64.
EskildsenT, TaipaleenmakiH, StenvangJ, AbdallahBM, DitzelN, NossentAY, BakM, KauppinenS, KassemM. 2011. MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo. Proc Natl Acad Sci U S A, 108:6139–6144.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
